Publikationen in Zusammenarbeit mit Forschern von Memorial Sloan Kettering Cancer Center (6)

2022

  1. Identifying FGFR2 fusions/rearrangements in cholangiocarcinoma patients using a novel cfDNA algorithm for treatment with RLY-4008, a highly selective irreversible FGFR2 inhibitor

    European Journal of Cancer, Vol. 174, pp. S116

2019

  1. Identification of resistance pathways specific to malignancy using organoid models of pancreatic cancer

    Clinical Cancer Research, Vol. 25, Núm. 22, pp. 6742-6755

  2. Use of machine-learning algorithms in intensified preoperative therapy of pancreatic cancer to predict individual risk of relapse

    Cancers, Vol. 11, Núm. 5

2016

  1. NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic Cancer

    Cell, Vol. 166, Núm. 4, pp. 963-976

2015

  1. Mouse Models of Pancreatic Ductal Adenocarcinoma

    Hematology/Oncology Clinics of North America, Vol. 29, Núm. 4, pp. 609-617

  2. Organoid models of human and mouse ductal pancreatic cancer

    Cell, Vol. 160, Núm. 1-2, pp. 324-338